The proteasome inhibitors market was valued at USD 10.78 Billion in 2024, driven by advancements in cancer treatments, particularly for hematologic malignancies. The market is anticipated to grow at a CAGR of 7.10% during the forecast period of 2025-2034, with values likely to reach USD 21.40 Billion by 2034.
Base Year
Historical Year
Forecast Year
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The industry is expanding due to the development in the research sector, providing treatment for multiple myeloma and drugs to treat pancreatic cancer. North America held the largest market share in 2018, however, it is anticipated to witness a slower growth during the forecast period because of the rising number of substitutes approved by the government, especially in the United States.
Proteasome inhibitors help in the prevention or delay in the degradation of proapoptotic factors. It facilitates the programmed cell death that ultimately cures the disease.
The various product types of proteasome inhibitors are:
Looks into the regional proteasome inhibitors markets like:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global proteasome inhibitors market is being driven by the enormous unmet demand and expanding applications of proteasome inhibitors in the treatment of blood cancer and primarily myeloma. The industry is further aided by the rising prevalence of cancer, globally, as proteasome has proved to be efficient for treating cancer indications. The ability of the drug is prompting vendors to conduct studies on the therapeutics effects of the product on solid tumours, hence, promoting the growth of the industry. The other factor leading to the growth of the proteasome inhibitors market is the application of proteasome inhibitors in the treatment of various health conditions. North America accounted for the largest industry share in 2018 due to the high incidences of multiple myeloma and non-Hodgkin’s lymphoma in the region. However, Europe and Asia, are expected to witness a significant growth during the forecast period owing to increased incidences of myeloma and rising sales of proteasome inhibitors in the regions.
The report presents a detailed analysis of the following key players in the global proteasome inhibitors market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 7.10% during the forecast period of 2025-2034, with the values likely to reach USD 21.40 Billion by 2034.
The market is estimated to grow in the forecast period of 2025-2034 to reach about USD 21.40 Billion by 2034.
The major drivers of the industry, such as the growing demand for proteasome inhibitors in the medical sector, growing incidences of cancer across the globe, increased government investment to develop the healthcare sector, and the growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing research and development activities and a rise in the number of clinical trials being conducted globally.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
Velcade, kyprolis, and ninlaro, among others, are the leading proteasome inhibitors products in the industry.
The major players in the industry are AbbVie Inc., Celgene Corp. (NASDAQ: CELG), Johnson & Johnson Services Inc. (NYSE: JNJ), The Takeda Pharmaceutical Company Limited, Others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share